查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1931266

鼻十二指肠管市场：依最终用户、产品类型、适应症、材料、销售管道、患者年龄层划分，全球预测（2026-2032年）

Nasoduodenal Tube Market by End User, Product Type, Indication, Material, Sales Channel, Patient Age Group - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，鼻十二指肠管市场价值将达到 10.2 亿美元，到 2026 年将成长至 10.6 亿美元，到 2032 年将达到 14.7 亿美元，年复合成长率为 5.33%。

关键市场统计数据
基准年 2025 10.2亿美元
预计年份：2026年 10.6亿美元
预测年份 2032 14.7亿美元
复合年增长率 (%) 5.33%

鼻十二指肠管的全面应用：临床作用、器材生命週期、对医疗环境的影响、说明临床医师采用的因素

鼻十二指肠管在经肠营养途径中扮演着独特且日益重要的角色，这得益于不断发展的临床实践、材料科学以及护理路径的重建。本文概述了该装置的临床用途、典型使用情况以及最有可能受益的患者群体，为深入探讨市场动态和策略优势奠定了基础。临床医生依靠鼻胃管来确保幽门后营养、降低误吸风险，并在经胃造瘻管口服营养不足时进行减压。这些临床需求与技术选择（例如材料选择和产品重量）密切相关，而这些因素会影响装置的性能和耐受性。

材料创新、不断发展的手术流程、监管重点以及医疗服务分散化如何重塑鼻十二指肠管的选择和应用模式

由于器械材料的创新、操作通讯协定的不断完善、监管趋势日益重视安全性以及医疗保健的去中心化，鼻十二指肠管领域正在经历变革。材料技术的进步正在拓展可用器械的性能范围，製造商正在探索聚氨酯和硅胶配方，以提高其生物相容性和柔软性。然而，在成本控制和供应链稳定是优先考虑因素的情况下，聚氯乙烯（PVC）仍然发挥着重要作用。这些材料的变化影响着临床医生的选择，尤其是在考虑插入的便利性、放置时间和患者舒适度时。与材料发展同步，器械设计的改进，例如加重型和非加重型，使得产品能够针对特定应用场景进行区分。这正在影响医疗团队如何选择用于预防误吸、经肠营养、胃减压等用途的器材。

美国近期关税调整对经济和供应链的影响，以及製造商和买家正在製定的策略应对措施

近期影响跨境贸易和医疗设备关税的动态变化，为销往美国市场的鼻十二指肠管的采购、供应链规划和定价策略带来了新的复杂性。关税分类和税率的变化会影响到岸成本，进而影响买家的采购决策和製造商的打入市场策略。对于依赖国际采购或海外生产的製造商而言，这些变化尤其重要，因为进口成本的增加会挤压利润空间，并需要重新评估与分销商和直接买家的合约条款。

细分市场分析揭示了终端用户环境、产品类型、适应症、材质、销售管道和年龄层如何影响临床和商业策略。

鼻十二指肠管市场的细分观点突显了临床需求领域，以及产品设计和分销策略如何针对不同的应用情境进行调整。对终端使用者环境的检验揭示了门诊手术中心、诊所、居家照护机构和医院之间在营运和采购方面的不同驱动因素。门诊和诊所优先考虑快速周转率、操作简便性和成本效益，而医院则优先考虑丰富的产品种类和与重症监护工作流程的兼容性。居家照护机构优先考虑看护者的易用性和清晰的长期管理说明。无配重管和配重管的差异十分显着。配重管便于置于幽门后，从而预防误吸并提高餵食耐受性；而当插入的便利性和患者舒适度是主要考虑因素时，无配重管可能更受欢迎。

详细分析区域趋势，揭示临床实践、采购机制和法规的差异如何影响全球主要丛集中医疗器材的采用。

鼻十二指肠器械的区域趋势差异显着，每个区域丛集都有其独特的临床实践、法规结构和分销基础设施，这些都会影响器械的推广和商业化策略。在美洲，先进的医院网路、不断扩展的门诊手术能力以及完善的采购流程共同促成了对安全性、临床熟练度和供应可靠性均得到验证的器械的需求。采购週期越来越注重合约价值和临床证据，而减少误嚥相关併发症的努力也推动了人们对专用幽门后入路器械的兴趣。在欧洲、中东和非洲地区，医疗保健系统多种多样，从集中式公共采购到私立专科中心不等。应对这种多样性需要弹性价格设定和监管策略，以及本地临床合作，以符合特定区域的指南和报销结构。

市场格局洞察，重点在于竞争格局、产品差异化、经销伙伴、临床证据重点和策略联盟。

鼻十二指肠管市场的竞争格局由成熟的医疗器材供应商和小规模的专业製造商组成，它们在产品设计、法规遵循和通路关係方面各有优势。主要企业凭藉着完善的品管系统、广泛的临床支援和培训计画以及供给能力脱颖而出。中型和专业领域的企业通常以其专长展开竞争，例如提供定製材料、独特的先进设计、儿童产品线，或服务更灵活的管道，如小规模诊所和居家医疗分销商。与经销商合作对于市场渗透至关重要，因为他们拥有成熟的物流网络、本地法规支援以及与采购团队的良好关係。

为加速产品推广应用，提出切实可行的策略建议，以协调产品创新、供应链韧性、法规遵循性和多通路商业化。

产业领导者应采取多管齐下的策略，在保障供应可靠性和扩大商业性覆盖范围的同时，加速临床应用。首先，产品开发应与临床需求保持一致，优先选择能够提升成人和儿童患者舒适度和植入成功率的材料和先进设计。同时，加大临床检验投入将有助于增强采购谈判的筹码。其次，应实现供应链多元化，考虑建立区域製造合作伙伴关係和双源采购安排，以在降低关税和物流风险的同时，保持成本竞争力。第三，应发展灵活的商业模式，将面向大规模机构买家的直接销售与小规模买家和居家医疗市场的分销协议和线上管道相结合，以确保所有临床场所的稳定供应。

采用透明的调查方法，结合对临床医生和采购负责人的初步访谈、严谨的二手证据综合分析以及有据可查的分析程序。

本研究整合了一手和二手讯息，旨在对鼻十二指肠器械市场进行严谨透明的分析。一手资讯包括对急诊和门诊临床医生、采购人员和分销合作伙伴进行的结构化访谈，从而获得关于器械性能、采购标准和运营限制的第一手资料。二手资讯包括监管文件、临床文献、器械标籤和已发布的操作指南。这些资讯来源有助于对临床适应症、安全性考虑和材料性能声明进行三角验证。数据检验包括将临床医生的回馈与产品规格和监管文件进行交叉比对，以确保数据的一致性并识别需要深入研究的领域。

最终的综合分析强调了临床需求、产品创新和营运韧性之间的相互作用，这将决定医疗设备相关人员的未来成功。

总之，鼻十二指肠管的应用领域受到临床需求、材料创新和不断变化的医疗服务模式的共同影响，这些因素共同塑造了产品的选择和采购行为。诸如预防误嚥和高效经肠营养临床需求明确了产品性能要求，而材料选择和产品评估标准则决定了产品在不同患者群体中的可用性和适用性。市场正在透过差异化的产品系列、更灵活的分销策略以及对培训和循证医学的重视来应对这些变化。同时，关税变化和监管审查等外部压力也要求供应链具备韧性，并采用适应性强的商业性策略。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依最终使用者分類的鼻十二指肠管市场

  • 门诊手术中心
  • 诊所
  • 居家医疗
  • 医院

第九章 依产品类型分類的鼻十二指肠管市场

  • 非加权类型
  • 加权公式

第十章 依适应症分類的鼻十二指肠管市场

  • 预防误嚥
  • 经肠营养
  • 胃减压

第十一章 依材料分類的鼻十二指肠管市场

  • 聚氨酯
  • PVC
  • 硅酮

第十二章 鼻十二指肠管市场销售管道

  • 离线
  • 在线的

第十三章 依病患年龄层分類的鼻十二指肠管市场

  • 成人版
  • 儿童

第十四章 鼻十二指肠管市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 鼻十二指肠管市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国鼻十二指肠管市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

17. 美国鼻十二指肠管市场

第十八章 中国鼻十二指肠管市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Acuataas Chemicals
  • Angiplast Pvt. Ltd.
  • Applied Medical Technology
  • Avanos Medical, Inc.
  • B. Braun
  • Becton, Dickinson and Company
  • Boston Scientific
  • Cardinal Health
  • ConvaTec
  • Cook Medical
  • Covidien（Medtronic）
  • GBUK Group
  • Guangdong Baihe Medical Technology Co., Ltd.
  • Halyard Health
  • Medline Industries
  • Poly Medicure Limited
  • QMD
  • Securmed
  • Skies Tech Products Pvt. Ltd.
  • Teleflex
  • Vygon
Product Code: MRR-7B550E008DF6

The Nasoduodenal Tube Market was valued at USD 1.02 billion in 2025 and is projected to grow to USD 1.06 billion in 2026, with a CAGR of 5.33%, reaching USD 1.47 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.02 billion
Estimated Year [2026] USD 1.06 billion
Forecast Year [2032] USD 1.47 billion
CAGR (%) 5.33%

Comprehensive introduction to nasoduodenal tubes explaining clinical roles, device lifecycles, care setting implications, and factors driving clinician adoption

The nasoduodenal tube occupies a specialized yet increasingly prominent role within enteral access strategies, driven by evolving clinical practice, material science, and care pathway reconfiguration. This introduction outlines the device's clinical purpose, typical deployment settings, and the patient cohorts most likely to benefit, setting the stage for a deeper discussion of market dynamics and strategic levers. Clinicians rely on nasoduodenal tubes for targeted post-pyloric feeding, aspiration risk mitigation, and decompression where gastric drainage is insufficient; those clinical imperatives intersect with technological choices such as material selection and product weighting to influence device performance and tolerability.

Beyond clinical indications, the device lifecycle-spanning design, procurement, clinician training, and point-of-care use-reflects a balance between procedural efficiency and patient comfort. Manufacturing quality, regulatory compliance, and supply chain reliability determine which products clinicians and procurement teams trust. As care delivery shifts increasingly toward outpatient and home settings, nasoduodenal tubes must align with simplified insertion protocols and robust instructions for non-hospital caregivers. Transitioning from hospital-centric use patterns to ambulatory surgical centers, clinics, and home care environments requires manufacturers and suppliers to prioritize user education, compatibility with feeding systems, and packaging that supports safe handling. This introduction frames the subsequent sections by emphasizing that clinical needs, material innovation, and distribution strategy together shape adoption pathways and the competitive landscape for nasoduodenal devices.

How material innovation, procedural evolution, regulatory focus, and care decentralization are reshaping nasoduodenal device selection and adoption patterns

The nasoduodenal tube landscape is undergoing transformative shifts driven by innovations in device materials, procedural protocols, regulatory emphasis on safety, and the decentralization of care. Material advances have broadened the performance envelope of available devices, with manufacturers exploring polyurethane and silicone formulations that offer improved biocompatibility and flexibility; at the same time, polyvinyl chloride remains relevant in contexts where cost containment and established supply chains dominate. These material changes influence clinician preferences, particularly when balancing insertion ease, dwell time, and patient comfort. Converging with materials development, device design refinements-such as weighted versus non-weighted options-have differentiated products for specific clinical use cases, affecting how teams select devices for aspiration prevention, enteral feeding, or gastric decompression.

Simultaneously, procedural standards have shifted toward earlier initiation of enteral nutrition and more conservative use of invasive alternatives, which increases reliance on reliable enteric access devices. This change intersects with care setting transformations: ambulatory surgical centers and clinics are assuming responsibilities once limited to inpatient wards, and home care providers increasingly manage long-term enteral strategies. Regulatory landscapes now emphasize traceability, sterility assurance, and post-market surveillance, compelling manufacturers to strengthen quality systems and documentation. Together, these shifts reshape procurement criteria, inform clinician training requirements, and create opportunity for companies that can align product design with multi-setting utility, regulatory robustness, and evidence-based performance claims. As a result, stakeholders that adapt across material science, clinical protocol integration, and distribution flexibility will capture the most strategic advantage.

Economic and supply chain implications of recent United States tariff shifts and the strategic responses manufacturers and purchasers are deploying

Recent policy developments affecting cross-border trade and medical device tariffs have introduced new complexity into procurement, supply chain planning, and pricing strategies for nasoduodenal tubes intended for the United States market. Changes to tariff classifications and duty rates influence landed costs, which in turn affect buyers' sourcing decisions and manufacturers' market access strategies. These shifts are particularly consequential for manufacturers that rely on international component sourcing or offshore production, as increased import costs can compress margins and necessitate reassessment of contract terms with distributors and direct purchasers.

In response, suppliers have pursued several mitigation approaches. Some have localized production or established additional regional manufacturing capacity to reduce exposure to tariffs and logistics variability. Others have restructured their supplier base to identify domestic or tariff-favored sources for critical raw materials and packaging. Procurement organizations and health systems have intensified focus on total landed cost analysis and contractual protections, including longer-term agreements that hedge against tariff volatility. Additionally, distributors have adjusted inventory strategies to smooth cost fluctuations and preserve supply continuity. These collective adaptations underscore that tariff changes do not operate in isolation; they interact with regulatory compliance costs, currency movements, and logistic constraints. Consequently, stakeholders must evaluate procurement strategies holistically and prioritize flexibility in sourcing to maintain clinical supply reliability while managing the economic impact of tariff regimes.

Segment-focused analysis revealing how end-user settings, product types, indications, materials, sales channels, and age groups shape clinical and commercial strategies

A segmentation-aware view of the nasoduodenal tube landscape helps clarify where clinical demand concentrates and how product design and channel strategy should align to serve different use cases. Examining end-user settings reveals distinct operational and procurement drivers across ambulatory surgical centers, clinics, home care environments, and hospitals: ambulatory and clinic settings emphasize rapid turnover, minimal procedural complexity, and cost efficiency, whereas hospitals prioritize a broad SKU mix and compatibility with intensive care workflows; home care environments focus on ease of use for caregivers and clear instructions for long-term management. Product-type distinctions between non-weighted and weighted tubes matter because weighted designs can facilitate post-pyloric placement for aspiration prevention and feeding tolerance, while non-weighted options may be preferred where ease of insertion and patient comfort are primary concerns.

Indication-based segmentation among aspiration prevention, enteral feeding, and gastric decompression clarifies clinical requirements that drive device choice, such as lumen configuration, tip design, and radiopacity. Material segmentation across polyurethane, PVC, and silicone further differentiates device performance and clinician preference: polyurethane and silicone often command preference for prolonged dwell and reduced irritation, while PVC is commonly selected for its cost advantages in short-term use. Sales channel segmentation indicates that direct sales relationships can support tailored contracts and clinician education, distributors provide broad network reach and inventory management, and online channels are increasingly relevant for smaller purchasers and home care buyers seeking convenience and rapid fulfillment. Patient age group segmentation into adult and pediatric cohorts imposes distinct size, flexibility, and safety requirements, and pediatric devices often demand specialized clinician training and regulatory considerations. Integrating these segmentation lenses reveals where manufacturers should prioritize R&D, packaging, labeling, and channel investments to match clinical intent and purchaser expectations across diverse care settings.

Detailed regional dynamics identifying how clinical practice, procurement mechanisms, and regulatory diversity influence device adoption across major global clusters

Regional dynamics for nasoduodenal devices vary considerably, with each geographic cluster presenting unique clinical practices, regulatory frameworks, and distribution infrastructures that influence adoption and commercialization tactics. In the Americas, a combination of advanced hospital networks, growing outpatient procedural capacity, and sophisticated purchasing processes creates demand for devices that demonstrate safety, clinician familiarity, and supply reliability. Procurement cycles tend to emphasize contract value and clinical evidence, and initiatives to reduce aspiration-related complications drive interest in devices tailored for post-pyloric access. Europe, the Middle East & Africa features a heterogeneous set of health systems ranging from centralized public procurement to private specialist centers; this diversity requires flexible pricing and regulatory strategies, as well as localized clinical engagement to address region-specific guidelines and reimbursement structures.

Asia-Pacific is marked by rapid adoption in ambulatory and home care settings and by varied regulatory maturity across countries; manufacturers often find opportunities by aligning product portfolios to local clinical guidelines, price sensitivities, and distribution partner capabilities. Across all regions, the decentralization of care and emphasis on patient comfort and reduced hospital stays call for devices that support simplified protocols and caregiver education. Regional supply chain resilience, compliance with local regulatory requirements, and strategic partnerships with distributors or direct sales teams remain central to successful market entry and expansion, while local clinical validation studies and training programs frequently accelerate acceptance among clinicians and procurement bodies.

Competitive landscape insights highlighting product differentiation, distribution partnerships, clinical evidence priorities, and strategic alliances that drive market positioning

Competitive dynamics in the nasoduodenal tube space are shaped by a mix of established device suppliers and smaller specialized manufacturers, each deploying different strengths across product design, regulatory compliance, and channel relationships. Leading firms tend to differentiate through robust quality systems, extensive clinical support and training programs, and the ability to supply consistent volumes to large hospital networks. Mid-sized and niche players often compete on specialization-offering tailored materials, unique tip designs, or pediatric-focused product lines-and by serving channels that demand agility, such as smaller clinics and home care distributors. Distributor partnerships remain critical for market penetration because they provide established logistics, local regulatory support, and relationships with procurement teams.

Innovation pathways center on materials science, ease-of-use features, and packaging that supports outpatient and home-care workflows. Companies investing in clinical evidence generation, including procedural outcome studies and tolerability assessments, gain credibility with clinicians and procurement officers. Additionally, firms that streamline regulatory submissions and post-market surveillance create competitive advantage by reducing time-to-adoption and minimizing supply disruptions. Strategic alliances between manufacturers and service providers-such as clinical education vendors, home-care providers, and feeding system suppliers-can extend value propositions and lock in preferred supplier status. Overall, the competitive environment favors organizations that combine product reliability with demonstrable clinical support and adaptable distribution strategies.

Actionable strategic recommendations that align product innovation, supply resilience, regulatory readiness, and multi-channel commercialization to drive adoption

Industry leaders should adopt a multi-pronged strategy that accelerates clinical adoption while protecting supply reliability and enhancing commercial reach. First, align product development with clinical needs by prioritizing materials and tip designs that improve patient comfort and placement success for both adult and pediatric populations; simultaneous investment in clinical validation will strengthen procurement conversations. Second, diversify supply chains and consider regional manufacturing partnerships or dual-sourcing arrangements to mitigate tariff and logistic risks while preserving cost competitiveness. Third, build flexible commercial models that combine direct sales for large institutional buyers with distributor agreements and online channel options for smaller purchasers and home care markets, ensuring consistent availability across all care settings.

In parallel, establish robust clinician training and caregiver education programs to reduce insertion errors and improve long-term outcomes, thereby increasing device preference among clinical teams. Invest in regulatory readiness and post-market surveillance to preempt compliance challenges and to support claims in procurement processes. Finally, pursue strategic collaborations with feeding system manufacturers and home-care service providers to create bundled offerings that simplify procurement and increase switching costs for customers. By executing these actions in a coordinated manner, industry leaders can create defensible positions that respond to clinical priorities, regulatory realities, and evolving care delivery models.

Transparent research methodology combining primary clinician and procurement interviews with rigorous secondary evidence synthesis and documented analytical steps

This research synthesizes primary and secondary inputs to deliver a rigorous, transparent understanding of the nasoduodenal device landscape. Primary inputs include structured interviews with clinicians across acute and ambulatory settings, procurement leaders, and distributor partners, providing firsthand perspectives on device performance, purchasing criteria, and operational constraints. Secondary inputs comprise regulatory filings, clinical literature, device labeling, and publicly available procedural guidelines; these sources support triangulation of clinical indications, safety considerations, and material performance claims. Data validation relied on cross-referencing clinician feedback with product specifications and regulatory documentation to ensure consistency and to identify areas requiring deeper inquiry.

Analytical methods combined qualitative thematic analysis with comparative assessment of product features, distribution configurations, and regional regulatory constraints. The approach emphasized transparency: methodologies for stakeholder selection, interview protocols, and criteria for evidence weighting are documented in the report appendix. Where gaps in public data existed, targeted expert consultations were conducted to clarify clinical practices and procurement decision drivers. Limitations are acknowledged and contextualized, including potential variability in national guidelines and rapid changes in procurement policies; readers are encouraged to consider local regulatory and clinical contexts when applying these insights. Overall, the methodology supports actionable conclusions while detailing the evidentiary basis and assumptions underpinning each key finding.

Final synthesis emphasizing the interplay of clinical needs, product innovation, and operational resilience that will determine future success for device stakeholders

In conclusion, the nasoduodenal tube sector is defined by an intersection of clinical priorities, material innovation, and shifting care delivery models that collectively shape product selection and procurement behavior. Clinical imperatives-such as aspiration prevention and efficient enteral feeding-articulate clear performance requirements, while material choices and product weighting determine usability and dwell-time suitability in different patient cohorts. The marketplace is responding through differentiated product portfolios, more flexible distribution strategies, and greater attention to training and evidence generation. Simultaneously, external pressures such as tariff changes and regulatory scrutiny necessitate resilient supply chains and adaptive commercial approaches.

Looking ahead, stakeholders who integrate clinician-facing education, robust regulatory processes, and multi-channel distribution will be best positioned to support evolving care pathways. Manufacturers that invest in human factors, pediatric-specific designs, and material improvements while maintaining supply chain agility will create the strongest value propositions. By synthesizing clinical needs with operational realities-from ambulatory centers and clinics to hospitals and home care-organizations can translate device-level innovations into measurable improvements in patient safety and care continuity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Nasoduodenal Tube Market, by End User

  • 8.1. Ambulatory Surgical Centers
  • 8.2. Clinics
  • 8.3. Home Care
  • 8.4. Hospitals

9. Nasoduodenal Tube Market, by Product Type

  • 9.1. Non-Weighted
  • 9.2. Weighted

10. Nasoduodenal Tube Market, by Indication

  • 10.1. Aspiration Prevention
  • 10.2. Enteral Feeding
  • 10.3. Gastric Decompression

11. Nasoduodenal Tube Market, by Material

  • 11.1. Polyurethane
  • 11.2. Pvc
  • 11.3. Silicone

12. Nasoduodenal Tube Market, by Sales Channel

  • 12.1. Offline
  • 12.2. Online

13. Nasoduodenal Tube Market, by Patient Age Group

  • 13.1. Adult
  • 13.2. Pediatric

14. Nasoduodenal Tube Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Nasoduodenal Tube Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Nasoduodenal Tube Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Nasoduodenal Tube Market

18. China Nasoduodenal Tube Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Acuataas Chemicals
  • 19.6. Angiplast Pvt. Ltd.
  • 19.7. Applied Medical Technology
  • 19.8. Avanos Medical, Inc.
  • 19.9. B. Braun
  • 19.10. Becton, Dickinson and Company
  • 19.11. Boston Scientific
  • 19.12. Cardinal Health
  • 19.13. ConvaTec
  • 19.14. Cook Medical
  • 19.15. Covidien (Medtronic)
  • 19.16. GBUK Group
  • 19.17. Guangdong Baihe Medical Technology Co., Ltd.
  • 19.18. Halyard Health
  • 19.19. Medline Industries
  • 19.20. Poly Medicure Limited
  • 19.21. QMD
  • 19.22. Securmed
  • 19.23. Skies Tech Products Pvt. Ltd.
  • 19.24. Teleflex
  • 19.25. Vygon

LIST OF FIGURES

  • FIGURE 1. GLOBAL NASODUODENAL TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NASODUODENAL TUBE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NASODUODENAL TUBE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES NASODUODENAL TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA NASODUODENAL TUBE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NASODUODENAL TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY NON-WEIGHTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY NON-WEIGHTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY NON-WEIGHTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY WEIGHTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY WEIGHTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY WEIGHTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY ASPIRATION PREVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY ASPIRATION PREVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY ASPIRATION PREVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY ENTERAL FEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY ENTERAL FEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY ENTERAL FEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY GASTRIC DECOMPRESSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY GASTRIC DECOMPRESSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY GASTRIC DECOMPRESSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS NASODUODENAL TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS NASODUODENAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS NASODUODENAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS NASODUODENAL TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS NASODUODENAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS NASODUODENAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS NASODUODENAL TUBE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA NASODUODENAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA NASODUODENAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA NASODUODENAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA NASODUODENAL TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA NASODUODENAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA NASODUODENAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA NASODUODENAL TUBE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA NASODUODENAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA NASODUODENAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA NASODUODENAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA NASODUODENAL TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA NASODUODENAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA NASODUODENAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA NASODUODENAL TUBE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA NASODUODENAL TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA NASODUODENAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA NASODUODENAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA NASODUODENAL TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA NASODUODENAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA NASODUODENAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA NASODUODENAL TUBE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE NASODUODENAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE NASODUODENAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE NASODUODENAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE NASODUODENAL TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE NASODUODENAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE NASODUODENAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE NASODUODENAL TUBE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST NASODUODENAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST NASODUODENAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST NASODUODENAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST NASODUODENAL TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST NASODUODENAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST NASODUODENAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST NASODUODENAL TUBE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA NASODUODENAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA NASODUODENAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. AFRICA NASODUODENAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA NASODUODENAL TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA NASODUODENAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA NASODUODENAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA NASODUODENAL TUBE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC NASODUODENAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC NASODUODENAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC NASODUODENAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC NASODUODENAL TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC NASODUODENAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC NASODUODENAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC NASODUODENAL TUBE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN NASODUODENAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. ASEAN NASODUODENAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. ASEAN NASODUODENAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN NASODUODENAL TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN NASODUODENAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN NASODUODENAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN NASODUODENAL TUBE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GCC NASODUODENAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GCC NASODUODENAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. GCC NASODUODENAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. GCC NASODUODENAL TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 125. GCC NASODUODENAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 126. GCC NASODUODENAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. GCC NASODUODENAL TUBE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION NASODUODENAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION NASODUODENAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPEAN UNION NASODUODENAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION NASODUODENAL TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION NASODUODENAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION NASODUODENAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION NASODUODENAL TUBE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS NASODUODENAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS NASODUODENAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS NASODUODENAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS NASODUODENAL TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS NASODUODENAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS NASODUODENAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS NASODUODENAL TUBE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. G7 NASODUODENAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. G7 NASODUODENAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. G7 NASODUODENAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. G7 NASODUODENAL TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 146. G7 NASODUODENAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 147. G7 NASODUODENAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. G7 NASODUODENAL TUBE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. NATO NASODUODENAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. NATO NASODUODENAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. NATO NASODUODENAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. NATO NASODUODENAL TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 153. NATO NASODUODENAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 154. NATO NASODUODENAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. NATO NASODUODENAL TUBE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL NASODUODENAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES NASODUODENAL TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES NASODUODENAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES NASODUODENAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES NASODUODENAL TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES NASODUODENAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES NASODUODENAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES NASODUODENAL TUBE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA NASODUODENAL TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA NASODUODENAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. CHINA NASODUODENAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA NASODUODENAL TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 168. CHINA NASODUODENAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 169. CHINA NASODUODENAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA NASODUODENAL TUBE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)